TGFB1 and cervical cancer: Through in vivo and in vitro experiments, our findings demonstrated that miR‐362 works as an anti‐oncomiR that inhibits proliferation and promotes apoptosis in cervical cancer cells via BAP31 and TGFβ/Smad pathway.